Research Explorer

Your browser does not support JavaScript or JavaScript is not enabled. Without JavaScript some functions of this webapplication may be disabled or cause error messages. To enable JavaScript, please consult the manual of your browser or contact your system administrator.

Researcher

Simon Bos

Awards & Distinctions

14 Results

2023

A comprehensive metabolite fingerprint of fibrostenosis in patients with Crohn’s disease

Simon BosTriana Lobatón OrtegaMartine De VosSophie Van WeldenVera PlekhovaEllen De PaepeLynn VanhaeckeDebby Laukens

A1 Journal Article in SCIENTIFIC REPORTS

MRI texture analysis of T2-weighted images is preferred over magnetization transfer imaging for readily longitudinal quantification of gut fibrosis

Isabelle De KockSimon BosLouke DelrueSophie Van WeldenPeter BunyardPieter HindryckxMartine De VosGeert VilleirsDebby Laukens

A1 Journal Article in EUROPEAN RADIOLOGY

2022

Effect of 5-hydroxytryptophan on fatigue in quiescent inflammatory bowel disease : a randomized controlled trial

Marie TruyensTriana Lobatón OrtegaMarc FerrantePeter BossuytSéverine VermeireLieven PouillonPieter DewintAnneline CremerHarald PeetersGuy Lambrecht et al.

A1 Journal Article in GASTROENTEROLOGY

Magnetic resonance texture analysis is superior to magnetization transfer imaging for longitudinal assessment of fibrosis in experimental colitis

Simon BosIsabelle De KockSophie Van WeldenPeter BunyardPieter HindryckxMartine De VosGeert VilleirsDebby Laukens

RXC008 suppresses fibrosis in a DSS model as measured by histopathology and magnetic resonance imaging

Peter BunyardDebby LaukensSimon BosAdriana GambardellaCliff JonesHelen McKeeverDiana BishopJane RobertsonAndrew Belfield

RXC008, a GI-targeted ROCK inhibitor, suppresses fibrosis and tissue injury in models of Crohn’s disease

Kirsty HouslayPeter BunyardKay EckersleyAdriana GambardellaAmy MarshallChris PiekarskiClifford JonesAndrew BelfieldDiana BischopHelen McKeever et al.

2021

A discriminative metabolic profile in the sera of Crohn's disease patients with fibrostenosis

Simon BosMartine De VosPieter HindryckxTriana Lobatón OrtegaLynn VanhaeckeDebby Laukens

Can serum metabolomics discriminate the Crohn’s disease fibrostenotic phenotype?

Simon BosSophie Van WeldenMartine De VosPieter HindryckxTriana Lobatón OrtegaLynn VanhaeckeDebby Laukens

Magnetization transfer MRI and T2-weighted MRI texture analysis allow non-invasive detection of intestinal fibrosis in a fibrosis-inducing chronic colitis mouse model

Simon BosIsabelle De KockLouke DelruePieter HindryckxMartine De VosGeert VilleirsDebby Laukens

Prevalence of fatigue and unrecognized depression in patients with inflammatory bowel disease in remission under immunosuppressants and biologicals

Marie TruyensElodie De RuyckGerard Bryan GonzalesSimon BosDebby LaukensMartine De Vos

A1 Journal Article in JOURNAL OF CLINICAL MEDICINE

2020

Integrin expression changes on the T cells subsets influence the response to vedolizumab in inflammatory bowel disease patients

Cara De GalanSophie Van WeldenSimon BosSimon TavernierTriana Lobatón OrtegaBryan GonzalesWouter Van MoerkerckeBeatrijs StrubbeHarald PeetersElisabeth Macken et al.

Metabolic modulation during intestinal fibrosis

Simon BosDebby Laukens

A1 Journal Article in JOURNAL OF DIGESTIVE DISEASES

2019

Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients

Cara De GalanSophie Van WeldenSimon BosSimon TavernierTriana Lobatón OrtegaBryan GonzalesWouter Van MoerkerckeBeatrijs StrubbeHarald PeetersElisabeth Macken et al.

2017

Holistic lipidomics of the human gut phenotype using validated ultra-high-performance liquid chromatography coupled to hybrid orbitrap mass spectrometry

Lieven Van MeulebroekEllen De PaepeVicky VercruysseBeata PomianSimon BosBruno LapauwLynn Vanhaecke

A1 Journal Article in ANALYTICAL CHEMISTRY